Alice Queen (ASX:AQX) - Managing Director, Andrew Buxton
Managing Director, Andrew Buxton
Source: YouTube (HotCopper Corporate Spotlight)
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Alice Queen (AQX) has raised $1.3 million through a placement.
  • The company will issue approximately 162.5 million shares at a price of $0.0008 per share
  • The funds will be used for working capital and for exploration drilling at Horn Island in Queensland
  • The new shares are not subject to shareholder approval and will be issued under the company’s placement capacity
  • Shares finished the day flat at 1 cent

Mineral exploration company, Alice Queen (AQX) has raised $1.3 million through a placement.

The company has received binding commitments to issue approximately 162.5 million shares at a price of $0.008 per share.

The funds will be used for working capital and for exploration drilling at Horn Island in Queensland.

The new shares are not subject to shareholder approval and will be issued under the company’s placement capacity.

Managing Director Andrew Buxton said he is pleased with the capital raising.

“We are very pleased with this result and take the opportunity to thank all the new and existing shareholders for their support and welcome them to the Alice Queen Register,” he said.

“With the current IP survey at Horn Island nearing completion, we are looking
forward to getting the drill bit spinning in February.”

The new shares are expected to be issued in the coming days.

Shares finished the day flat at 1 cent.

AQX by the numbers
More From The Market Online
The Market Online Video

Market Close: Consumer stocks drag market lower; Alara starts copper production in Oman

The ASX200 has closed the day down 0.15 per cent at 7724 points.
The Market Online Video

Orcoda welcomes Maree Adshead as Non-Executive Director

Orcoda (ASX:ODA) has welcomed Maree Adshead as an independent Non-Executive Director.

Cynata Therapeutics advances Phase 2 trial for high-risk aGvHD treatment

The market has responded favourably to Cynata Therapeutics' announcement regarding its Phase 2 clinical trial on…
The Market Online Video

Market Update: ASX trades flat as materials leads the market

The ASX200 is trading flat this afternoon, up just .10 of a per cent in line…